`Patent Owner’s Objections to Evidence
`Filed on behalf of Patent Owner Genentech, Inc. by:
`
`David L. Cavanaugh (Reg. No. 36,476)
`Rebecca A. Whitfield (Reg. No. 73,756)
`Robert J. Gunther, Jr. (Pro Hac Vice)
`Lisa J. Pirozzolo (Pro Hac Vice)
`Kevin S. Prussia (Pro Hac Vice)
`Andrew J. Danford (Pro Hac Vice)
`WILMER CUTLER PICKERING
` HALE AND DORR LLP
`1875 Pennsylvania Ave., NW
`Washington, DC 20006
`
`Adam R. Brausa (Reg. No.
`60,287)
`Daralyn J. Durie (Pro Hac Vice)
`Durie Tangri LLP
`217 Leidesdorff Street
`San Francisco, CA 94111
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`PFIZER, INC.,
`Petitioner,
`
`v.
`
`GENENTECH, INC.,
`Patent Owner.
`
`Case IPR2017-01488
`U.S. Patent 6,407,213
`
`PATENT OWNER’S OBJECTIONS TO EVIDENCE
`PURSUANT TO 37 C.F.R. § 42.64
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.64, Patent Owner Genentech, Inc. presents the
`
`IPR2017-01488
`Patent Owner’s Objections to Evidence
`
`
`following objections to evidence served with the Petition of Pfizer, Inc.
`
`(“Petitioner”).
`
`Genentech objects to Exhibit 1003, Declaration of Jefferson Foote, Ph.D., in
`
`Support of Pfizer’s Petition for Inter Partes Review of U.S. Patent No. 6,407,213.
`
`Genentech specifically objects to ¶¶ 29-32, 33-41, 48, 51-52, 56-57, 62, 65, 73, 80,
`
`84-106, 108-120, 121, 125, 129-130, 134, 139, 143, 156-161, 163-164, 167-168,
`
`170-172, 174-176, 179-186, 188, 190-191, 193-194, 196-199, 201-202, 204-212,
`
`214, 216-222, 224-228, 230-240, 242-278, 280-291, 293-310, 312-316, 318-322,
`
`324-327, 330-353 and all paragraphs that rely on those paragraphs as lacking a
`
`disclosed basis of sufficient facts or data (FRE 705; 37 C.F.R. § 42.65), not being
`
`based on sufficient facts or data, the product of reliable principles and methods,
`
`and/or a reliable application of the principles and methods to the facts (FRE 702,
`
`703), and being misleading and/or confusing (FRE 403).
`
`Genentech objects to Exhibit 1004, Declaration of Timothy Buss, in Support
`
`of Pfizer’s Petition for Inter Partes Review of U.S. Patent No. 6,407,213.
`
`Genentech specifically objects to ¶¶ 15-16, 18, 30-33, 43-45, 53-55, 63, 67, 69-70
`
`and all paragraphs that rely on those paragraphs as inadmissible hearsay (FRE
`
`802), lacking a disclosed basis of sufficient facts or data (FRE 705; 37 C.F.R. §
`
`42.65), not being based on sufficient facts or data, the product of reliable principles
`
`
`
`- 1 -
`
`
`
`and methods, and/or a reliable application of the principles and methods to the
`
`IPR2017-01488
`Patent Owner’s Objections to Evidence
`
`
`facts (FRE 702, 703), and being misleading and/or confusing (FRE 403).
`
`Respectfully submitted,
`
`Date: December 15, 2017
`
`
`
`/David L. Cavanaugh/
`David L. Cavanaugh
`Registration No. 36,476
`Counsel for Patent Owner
`
`
`WILMER CUTLER PICKERING HALE AND DORR LLP
`1875 PENNSYLVANIA AVENUE NW
`WASHINGTON, DC 20006
`TEL: 202-663-6000
`FAX: 202-663-6363
`EMAIL: david.cavanaugh@wilmerhale.com
`
`
`
`
`
`- 2 -
`
`
`
`IPR2017-01488
`Patent Owner’s Objections to Evidence
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that, on December 15, 2017, I caused a true and correct copy
`of the following materials:
`
`
`
` Patent Owner’s Objections to Evidence
`
`to be served via electronic mail on the following attorneys of record:
`
`Amanda Hollis
`KIRKLAND & ELLIS LLP
`amanda.hollis@kirkland.com
`300 North LaSalle, Chicago, IL 60654
`
`Stefan M. Miller, Ph.D.
`Stefan.miller@kirkland.com
`601 Lexington Avenue, New York, NY 10022
`
`Benjamin A. Lasky
`benjamin.lasky@kirkland.com
`601 Lexington Avenue, New York, NY 10022
`
`Sarah K. Tsou
`sarah.tsou@kirkland.com
`601 Lexington Avenue, New York, NY 10022
`
`Mark C. McLennan
`mark.mclennan@kirkland.com
`601 Lexington Avenue, New York, NY 10022
`
`Christopher J. Citro
`christopher.citro@kirkland.com
`601 Lexington Avenue, New York, NY 10022
`
`Karen Younkins
`karen.younkins@kirkland.com
`333 South Hope Street, Los Angeles, CA 90071
`
`
`
`
`- 3 -
`
`
`
`IPR2017-01488
`Patent Owner’s Objections to Evidence
`
`
`Pfizer_Genentech_IPRs@kirkland.com
`
`
`/Vera A. Shmidt/
`Vera A. Shmidt
`Reg. No. 74,944
`Wilmer Cutler Pickering Hale and Dorr LLP
`60 State Street
`Boston, MA 02109
`(617) 526-6137
`
`
`- 4 -
`
`
`
`
`
`
`